Comparative evaluation of NASBA HIV-1 RNA QT, AMPLICOR-HIV monitor, and QUANTIPLEX HIV RNA assay, three methods for quantification of human immunodeficiency virus type 1 RNA in plasma.
about
Stability of human immunodeficiency virus RNA in blood specimens as measured by a commercial PCR-based assayIntra-assay performance characteristics of five assays for quantification of human immunodeficiency virus type 1 RNA in plasmaDeterminations of levels of human immunodeficiency virus type 1 RNA in plasma: reassessment of parameters affecting assay outcome. TUBE Meeting Workshop Attendees. Technology Utilization for HIV-1 Blood Evaluation and Standardization in Pediatrics.Detection of human immunodeficiency virus type 1 (HIV-1) RNA in pools of sera negative for antibodies to HIV-1 and HIV-2.Comparison of NucliSens and Amplicor monitor assays for quantification of human immunodeficiency virus type 1 (HIV-1) RNA in plasma of persons with HIV-1 subtype A infection in Abidjan, Côte d'Ivoire.Efficiencies of four versions of the AMPLICOR HIV-1 MONITOR test for quantification of different subtypes of human immunodeficiency virus type 1.Highly sensitive methods for quantitation of human immunodeficiency virus type 1 RNA from plasma, cells, and tissues.Quantitation of human immunodeficiency virus type 1 RNA in different biological compartments.Single rapid real-time monitored isothermal RNA amplification assay for quantification of human immunodeficiency virus type 1 isolates from groups M, N, and OAbsolute copy number and relative change in determinations of human immunodeficiency virus type 1 RNA in plasma: effect of an external standard on kit comparisons.Rheonix CARD(®) Technology: An Innovative and Fully Automated Molecular Diagnostic DeviceEvaluation of a quality assurance program for quantitation of human immunodeficiency virus type 1 RNA in plasma by the AIDS Clinical Trials Group virology laboratoriesHuman immunodeficiency virus (HIV) RNA quantitation using the Amplicor HIV-1 Monitor test: not all yellow-top tubes are suitable for blood collection.Comparison of the Amplicor HIV-1 monitor test and the nucleic acid sequence-based amplification assay for quantitation of human immunodeficiency virus RNA in plasma, serum, and plasma subjected to freeze-thaw cycles.The relationship between cocaine use and human papillomavirus infections in HIV-seropositive and HIV-seronegative women.Past, present and future molecular diagnosis and characterization of human immunodeficiency virus infections.RT-PCR detection of HIV in Republic of Macedonia.Comparison of the QUANTIPLEX HIV-1 RNA 2.0 assay with the AMPLICOR HIV-1 MONITOR 1.0 assay for quantitation of levels of human immunodeficiency virus type 1 RNA in plasma of patients receiving stavudine-didanosine combination therapyClinical evaluation of an in-house reverse transcription-competitive PCR for quantitation of human immunodeficiency virus type 1 RNA in plasmaReproducibility and performance of the second-generation branched-DNA assay in routine quantification of human immunodeficiency virus type 1 RNA in plasmaDesign and evaluation of a human immunodeficiency virus type 1 RNA assay using nucleic acid sequence-based amplification technology able to quantify both group M and O viruses by using the long terminal repeat as target.Comparison of levels of human immunodeficiency virus type 1 RNA in plasma as measured by the NucliSens nucleic acid sequence-based amplification and Quantiplex branched-DNA assays.Stability of plasma human immunodeficiency virus load in VACUTAINER PPT plasma preparation tubes during overnight shipment.Comparison of the frequencies and levels of human immunodeficiency virus type 1 markers in specimens from chronically infected human T-lymphocyte cultures and from patients.In vitro p24 antigen-stimulated lymphocyte proliferation and beta-chemokine production in human immunodeficiency virus type 1 (HIV-1)-seropositive subjects after immunization with an inactivated gp120-depleted HIV-1 immunogen (Remune)Clinical comparison of an enhanced-sensitivity branched-DNA assay and reverse transcription-PCR for quantitation of human immunodeficiency virus type 1 RNA in plasma.Evaluation of the Nuclisens HIV-1 QT assay for quantitation of human immunodeficiency virus type 1 RNA levels in plasma.Entirely automated quantification of human immunodeficiency virus type 1 (HIV-1) RNA in plasma by using the ultrasensitive COBAS AMPLICOR HIV-1 monitor test and RNA purification on the MagNA pure LC instrument.Development of a reverse transcriptase PCR-enzyme-linked immunosorbent assay for quantification of human immunodeficiency virus type 1 RNA in plasma: comparison with commercial quantitative assays.Obtaining unacceptable results in assays for quantitation of human immunodeficiency virus type 1 RNA in plasma samples.
P2860
Q33656743-6FE6C010-9C61-4607-8B9A-D186FF794415Q33660617-02E92868-60D7-4527-ACB5-693F2593EF14Q33668265-F37D548C-EF43-445A-9240-F427DF03F1F8Q33668746-F3763D21-0E39-4B8E-9CC8-1E98C90A7207Q33681662-F8416354-F2F0-44E6-9D94-CFF64913A532Q33958078-A2112BFE-B8AA-46BB-9EF5-00EC477C21A0Q33959997-52C012F8-C763-4E24-8AFE-92B1498E73AFQ33966350-F513DBC6-77E5-423C-9AC7-A5244A3EC0AFQ33971897-D4EC43E6-4CF2-4585-82A5-3958B9371A23Q34073785-62A6A5D5-31F9-4E38-94C1-A4FE79493A9FQ36059904-D11679C2-1BC7-44CD-A94E-6BA0CF64ACDBQ36541331-8A859AE0-A270-482D-9330-598E2499D6FBQ36544240-82157BAA-BA8A-4766-BE2C-5D8EAA1324E7Q36548250-F73E1EEF-8A58-4004-94C6-AC4AC86D651EQ36572919-2483DD4C-A5B3-46D3-8CD7-84B0E066E9E1Q36779718-E55FCAC0-1835-493A-9C24-3582B60E5005Q37855816-08CD7615-82FA-427F-B1E1-31BF406EB8DFQ39443872-3F32796F-AFA8-48D8-9ADE-396DEA8A0AF6Q39446249-1C398465-E117-417A-9CBB-402257DE442EQ39447554-EA16C612-62C3-44CF-BEAF-7D6382FA3E57Q39449534-487E4286-183C-4914-97DF-ECD49E849BC1Q39467920-76BC4416-9C4E-4D1E-8D85-93054848C72AQ39468088-80FA771B-C300-42B1-817B-7D4933D87CFDQ39548132-1F0F1D42-7779-428B-8CD5-DF1D1852A171Q39552124-E27839FD-BA9B-4B10-8918-ECB51BC199A1Q39552641-0243FF3F-0ACC-40BC-A934-2CA072157A15Q39556258-40B6E583-534D-4956-87D6-AF6E21DD19ECQ39735390-F20DE2D9-66A7-4C2F-9671-9272E7752BC2Q40024806-A4C8A2EA-3401-4FC3-A0CF-60F0D3C22C38Q42728263-86D04C4C-7163-42C6-965B-4972DDD38C29
P2860
Comparative evaluation of NASBA HIV-1 RNA QT, AMPLICOR-HIV monitor, and QUANTIPLEX HIV RNA assay, three methods for quantification of human immunodeficiency virus type 1 RNA in plasma.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Comparative evaluation of NASB ...... cy virus type 1 RNA in plasma.
@ast
Comparative evaluation of NASB ...... cy virus type 1 RNA in plasma.
@en
type
label
Comparative evaluation of NASB ...... cy virus type 1 RNA in plasma.
@ast
Comparative evaluation of NASB ...... cy virus type 1 RNA in plasma.
@en
prefLabel
Comparative evaluation of NASB ...... cy virus type 1 RNA in plasma.
@ast
Comparative evaluation of NASB ...... cy virus type 1 RNA in plasma.
@en
P2093
P2860
P1476
Comparative evaluation of NASB ...... ncy virus type 1 RNA in plasma
@en
P2093
Marissens D
P2860
P304
P407
P577
1996-05-01T00:00:00Z